Product Description
Chlorthalidone is a medication used in the management and treatment of hypertension. It is in the thiazide-like diuretics class of drugs. Chlorthalidone is a thiazide-like sulfonamide-derived diuretic that has been FDA approved since 1960 for the management of hypertension. It is also used in the treatment of edema (Sourced from: https://www.ncbi.nlm.nih.gov/books/NBK553174/)
Mechanisms of Action: NCCT Inhibitor
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Oral
FDA Designation: *
Approval Status: Approved
Approved Countries: Algeria | Argentina | Australia | Austria | Bangladesh | Belgium | Brazil | Bulgaria | Canada | Chile | Colombia | Croatia | Cyprus | Czech | Dominican Republic | Ecuador | Egypt | France | Germany | Greece | Hong Kong | Hungary | India | Ireland | Italy | Korea | Lebanon | Malaysia | Mexico | Morocco | Netherlands | New Zealand | Pakistan | Peru | Philippines | Poland | Portugal | Romania | Russia | Serbia | Slovakia | Slovenia | South Africa | Spain | Sri Lanka | Sweden | Taiwan | Thailand | Tunisia | Turkey | Ukraine | United Arab Emirates | United Kingdom | United States | Venezuela | Vietnam
Approved Indications: None
Known Adverse Events: None
Company: Takeda
Company Location: TOKYO M0 103-8668
Company CEO:
Additional Commercial Interests: None
Clinical Description
Countries in Clinic: Mexico
Active Clinical Trial Count: 1
Recent & Upcoming Milestones
Highest Development Phases
Phase 3: Hypertension
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|---|
NCT04927299 |
SIL-30601-III-20(1) | P3 |
Completed |
Hypertension |
2023-08-15 |
5% |
2025-03-14 |
Patient Enrollment|Primary Endpoints|Treatments |
Recent News Events
Date |
Type |
Title |
|---|---|---|
|
10/26/2023 |
News Article |
Dengue Vaccine Market to Grow at a Surprising Growth of USD 1.28 Billion By 2030 |
|
10/11/2023 |
News Article |
Dengue Vaccine Market to Witness Substantial Growth of USD 1.28 Billion by 2030 |
|
05/29/2023 |
News Article |
Calcium Channel Blockers Market Predicted to Reach $24 Billion by 2031, Propelled by 5.7% CAGR – TMR Study |
|
03/16/2022 |
News Article |
Diuretics Global Market Report 2022 |